Pharmacology/Therapeutics/Toxicology Research Award
Forecasted
Pharmacology/Therapeutics/Toxicology Research Award honors researchers for sustained work on dental drugs, recognizing advances in understanding their mechanisms, efficacy, or safety rather than funding new projects.
Funder: American Association for Dental, Oral, and Craniofacial Research
Due Dates (Anticipated): September 2027 (Applications close, anticipated)
Funding Amounts: $3,500 monetary prize and commemorative plaque
Summary: Recognizes sustained, outstanding peer-reviewed research on the mechanisms, efficacy, or safety of drugs used in dentistry.
Key Information: Only IADR members may be nominated; this award honors research achievements rather than funding proposed projects.
Description
Established by the IADR Pharmacology/Therapeutics/Toxicology (PTT) Group, this award is part of the IADR Distinguished Scientist Awards. It recognizes outstanding and sustained peer-reviewed research that advances understanding of the mechanisms, efficacy, or safety of drugs used to treat dental disease and associated symptoms, including pain and peri-operative apprehension.
The scope includes basic and clinical pharmacology studies of analgesics, anesthetics, sedatives, fluorides, and other drug classes used by dentists. Rather than supporting a proposed research project, the award honors an established record of research achievement in dental pharmacology, therapeutics, and toxicology. Recipients are selected by the IADR Science Awards Committee.
